Isoray - Innovative Brachytherapy
Clinical Oncology
Five Year Prostate-specific Antigen Outcomes after Caesium Prostate Brachytherapy
Authors: R.M. Benoit, R.P. Smith, S. Beriwal
Published: 05/08/2014

“Cesium provides everything we want for prostate brachytherapy as both a monotherapy and in combination therapy, including delivery of a high dose of radiation more quickly for high risk patients in a low dose rate ‘setting.’” 

Dr. Bernard W. Taylor, MD

Texas Oncology - Longview Cancer Center